1 asset in Functional Pancreatic Neuroendocrine Tumor
Therapeutic assets addressing Functional Pancreatic Neuroendocrine Tumor, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Cabozantinib Functional Pancreatic Neuroendocrine Tumor | National Cancer Institute (NCI) | P3 | NR () |